Blockers H2-receptors, ketoconazole, iron preparations, sodium fluoride, tetracyclines, phenytoin, holinoblokatory, mekamilamin - reduced absorption, due to which the effectiveness of these drugs is reduced.
Amphetamines, quinidine - decrease in excretion and increase in toxic effect.
Pancrelolipase - decreased efficiency.
Methenamine - oppression of transformation into formaldehyde alkalization of urine reduces its effectiveness; simultaneous appointment is not recommended.
Vitamins of the group D - Hypermagnia, especially in patients with chronic kidney disease.
The resin of sodium polystyrene-sulfonate is alkalosis.
Sucralfate is a risk of aluminum intoxication.
Fluoroquinolones - crystalluria, nephrotoxicity, with a joint admission control of urine and kidney status is necessary.
Salicylates - with simultaneous admission with the drug, excretion increases, dosage adjustment is necessary.
Ammonium chloride, ascorbic acid, potassium and sodium phosphate, racemetionine and other means, acidifying urine, - the effectiveness of these drugs decreases due to alkalinization of urine when taking an antacid.